Terms: = Uterine cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
191 results:
1. Transcriptome analysis of an akt inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/akt pathway through targeted inhibition of TPX2 in endometrial cancer.
Yang M; Mao X; Li L; Yang J; Xing H; Jiang C
Cancer Med; 2024 Mar; 13(5):e6958. PubMed ID: 38466034
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
4. Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
Wang Y; He M; He T; Ouyang X; Shen X; Shi W; Huang S; Xiang L; Zou D; Jiang W; Yang H
Br J Cancer; 2024 Apr; 130(6):987-1000. PubMed ID: 38253702
[TBL] [Abstract] [Full Text] [Related]
5. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/akt axis and VEGF-C secretion.
Mei X; Xiong J; Liu J; Huang A; Zhu D; Huang Y; Wang H
Cancer Lett; 2024 Mar; 584():216609. PubMed ID: 38211648
[TBL] [Abstract] [Full Text] [Related]
6. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer.
Hu Y; Jiang N; Wang X; Wu X; Bo J; Chen Y; Zeng Y; Wei X; Zhang H; Li M
Life Sci; 2024 Feb; 338():122389. PubMed ID: 38160786
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
8. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
[TBL] [Abstract] [Full Text] [Related]
10. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
Hao S; Meng Q; Sun H; Yang X; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Mol Carcinog; 2024 Feb; 63(2):339-355. PubMed ID: 37988232
[TBL] [Abstract] [Full Text] [Related]
11. Increased Gene Expression of
Parida P; Lewis S; Sharan K; Kamal MV; Kumar NAN; Godkhindi VM; Varambally S; Rangnekar VM; Rao M; Damerla RR
Cells; 2023 Oct; 12(21):. PubMed ID: 37947608
[No Abstract] [Full Text] [Related]
12. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/akt pathway.
Chen R; Fang T; Liu N; Shi X; Wang J; Yu H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238
[TBL] [Abstract] [Full Text] [Related]
13. Genomic profile of Chinese patients with endometrial carcinoma.
Li J; Li X; Quan C; Li X; Wan C; Wu X
BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
[TBL] [Abstract] [Full Text] [Related]
14. MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis.
Zhang Y; Wang J; Fan Y; Lang F; Fu F; Liu Q
Clin Transl Oncol; 2024 Mar; 26(3):653-663. PubMed ID: 37523078
[TBL] [Abstract] [Full Text] [Related]
15. Integrated analysis identifies rac3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.
Huang P; Qian Y; Xia Y; Wang S; Xu C; Zhu X; Gao Q
J Cell Mol Med; 2023 Aug; 27(16):2385-2397. PubMed ID: 37386813
[TBL] [Abstract] [Full Text] [Related]
16. Asparanin A exerts cytotoxicity on human endometrial cancer Ishikawa cells via regulating miR-6236-p5_4 expression.
Zhang F; Zhang XX; Zhang JG; Thakur K; Simal-Gandara J; Prieto MA; Khan MR; Cao H; Wei ZJ
Food Chem Toxicol; 2023 Aug; 178():113900. PubMed ID: 37369310
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer.
Kim J; Kim SI; Kim NR; Kim H; Kim HS; Chung HH; Kim JW; Lee C; Lee M
Gynecol Oncol; 2023 Jul; 174():231-238. PubMed ID: 37236032
[TBL] [Abstract] [Full Text] [Related]
18. ITGA5 promotes tumor angiogenesis in cervical cancer.
Xu X; Shen L; Li W; Liu X; Yang P; Cai J
Cancer Med; 2023 May; 12(10):11983-11999. PubMed ID: 36999964
[TBL] [Abstract] [Full Text] [Related]
19. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
20. Mechanistic analysis of endothelial lipase G promotion of the occurrence and development of cervical carcinoma by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase signalling pathway.
Huang J; Liu R; Zhang Y; Sheng X
J Obstet Gynaecol; 2023 Dec; 43(1):2151353. PubMed ID: 36606668
[TBL] [Abstract] [Full Text] [Related]
[Next]
